BQ Prime's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer BQ Prime's subscribers an opportunity to expand their understanding of companies, sectors and the economy.
HDFC Securities Retail Research
Dr. Reddy's Laboratories Ltd. is one of the leading pharmaceutical companies in India with presence in the formulation segments and pharmaceutical services and active ingredients business. Company has done backward integration for key active pharma ingredients.
Globally, the company is present in most markets with the U.S. and India accounting for ~35% and 20% of overall sales. Dr. Reddy's has a good compliance track record. Cost control measures well as productivity improvement, synergies through partnerships and acquisitions, strong execution, and product-specific opportunities would be key growth drivers for the company.
A strong product pipeline in the U.S. generic business would lead to healthy growth in U.S. sales in the next two-three years.
In the domestic formulation space, a likely revival in acute therapies and expected traction in the acquired portfolio would be key drivers for India business. However, the PSAI segment's performance is expected to be soft in the near term with a likely gradual improvement.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
